Cargando…
5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling
Disseminated cancer cells (DCCs) in secondary organs can remain dormant for years to decades before re-activating into overt metastasis. Microenvironmental signals leading to cancer cell chromatin remodeling and transcriptional reprogramming appear to control onset and escape from dormancy. Here, we...
Autores principales: | Singh, Deepak K., Carcamo, Saul, Farias, Eduardo F., Hasson, Dan, Zheng, Wei, Sun, Dan, Huang, Xin, Cheung, Julie, Nobre, Ana Rita, Kale, Nupura, Sosa, Maria Soledad, Bernstein, Emily, Aguirre-Ghiso, Julio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592471/ https://www.ncbi.nlm.nih.gov/pubmed/37267946 http://dx.doi.org/10.1016/j.celrep.2023.112560 |
Ejemplares similares
-
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy
por: Khalil, Bassem D., et al.
Publicado: (2021) -
Experimental search for DCCs using robust observables
por: Mukhopadhyay, Debsankar
Publicado: (1998) -
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012) -
7th IFAC Workshop on Distributed Computer Control Systems : DCCS '86
Publicado: (1986) -
NR2F1 controls tumor cell dormancy via SOX9 and RARβ driven quiescence programs
por: Sosa, Maria Soledad, et al.
Publicado: (2015)